Cystatin C and cardiac hypertrophy in primary hypertension

References

• Laterza OF, Price CP, Scout MG. Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem. 2002;48:699–707.
   PubMed Web of Science ®Google Scholar
• Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37:79–83.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Takkar H, Edwards RG, Wlikie M, White T, Grubb AO, . Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47:312–318.
   PubMed Web of Science ®Google Scholar
• Coll E, Botey A, Alvarez L, Poch E, Quinto L, Taurina A, . Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29–34.
   PubMed Web of Science ®Google Scholar
• Knight EL, Verhave JC, Spiegelman D, Hillege HL, De Zeeuw D, Curhan GC, . Factors influencing serum cystatin c levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–1421.
   PubMed Web of Science ®Google Scholar
• Köttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J. Serum cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2008;51:385–394.
   PubMed Web of Science ®Google Scholar
• Jernberg T, Lindahal B, James S, Larsson A, Hansson LO, Wallentin L. Cystatin C: A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation. 2004;110:2342–2348.
   PubMed Web of Science ®Google Scholar
• Shilipak MG, Katz R, Fried LF, Seliger S, Newman A, Siskovick DS, . Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol. 2005;45:268–271.
   Google Scholar
• Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, . Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, . Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142:497–505.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Wassel FCL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, . Cystatin C and mortality risk in the elderly: The health, aging and body composition study. J Am Soc Nephrol. 2006;17:254–261.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, . Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237–246.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Levey AS. Chronic kidney disease in the elderly – How to assess risk. N Engl J Med. 2005;352:2122–2124.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Okura T, Liu J, Miyoshi K, Fukuoka T, Hiwada K, . Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens Res. 2003;26:895–899.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
   Google Scholar
• Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behering Nephelometer II system. Scand J Clin Lab Invest. 1999; 59:1–8.
   PubMed Web of Science ®Google Scholar
• Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results from a survey of echocardiographic measurements. Circulation. 1978;58:1072–1083.
   PubMed Web of Science ®Google Scholar
• Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H, . Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, . Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450–458.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlöf B, Aalto T, . Impact of different partition values on the prevalence of left ventricular hypertrophy and concentric geometry in a large hypertensive population: The LIFE study. Hypertension. 2000;35:6–12.
   PubMed Web of Science ®Google Scholar
• Valero FA, Martinez-Vea A, Bardaji A, Gutierrez C, Garcia C, Richart C, . Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1999;10:1020–1026.
   PubMed Web of Science ®Google Scholar
• Ix JH, Schipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident Heart failure among persons with coronary heart disease. Data from the Heart and Soul Study. Circulation. 2007;115:173–179.
   PubMed Web of Science ®Google Scholar
• Djoussé L, Kurth T, Gaziano JM. Cystatin C and risk of heart failure in the Physicians’ Health Study(PHS). Am Heart J. 2008;155:82–86.
   PubMed Web of Science ®Google Scholar
• Piñón P, Kaski SC. Inflammation, atherosclerosis and cardiovascular disease risk: PAPP-A, Lp-PLA2 and cystatin C. New insights or redundant information? Rev Esp Cardiol. 2006;59:247–258.
   PubMedGoogle Scholar
• Bardaji A, Martinez Vea A. Chronic Kidney diasease and the heart. Linked pathologies. Rev Esp Cardiol. 2008;61(suppl 2): 41–51.
   Google Scholar
• Mitsnefes M, Timbal T, Kartal J, Kathman T, Mishra J, Devarajan P. Serum cystatin C and left ventricular diastolic dysfunction in children with chronic kidney disease. Pediatr Nephrol. 2006;21:1293–1298.
   Google Scholar
• Ix JH, Shlipak MG, Chertow GM, Ali S, Schiller NB, Whooley MA. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: Data from the Heart and Soul Study. J Cardiac Fail. 2006;12:601–607.
   Google Scholar
• Levin A, Thompson CR, Ethier J, Carlisle EJF, Tobe S, Mendelssohn D, . Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis. 1999;34:125–134.
   PubMed Web of Science ®Google Scholar
• Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis. 2005;46:320–327.
   PubMed Web of Science ®Google Scholar
• Leoncini G, Ratto E, Viazzi F, Conti N, Falqui V, Parodi A, . Global risk stratification in primary hypertension: The role of the kidney. J Hypertens. 2008;26:427–432.
   PubMedGoogle Scholar
• Kestenbaum B, Rudser KD, de Boer IH, Peralta CA, Fried LF, Shlipak MG, . Differences in kidney function and incident hypertension: The multi-ethnic study of atherosclerosis. Ann Intern Med. 2008;148:501–508.
   PubMed Web of Science ®Google Scholar
• Bertomeu V, Fácila L, González-Juanatey JR, Cea-Calvo L, Aznar J, Mazón P, . Blood pressure control in hypertensive patients with left ventricular hypertrophy. The VIIDA Study. Rev Esp Cardiol. 2007;60:1257–1263.
   Google Scholar
• Peralta CA, Whooley MA, Ix JH, Shlipak MG. Kidney function and systolic blood pressure. New insights from cystatin C: Data from the Heart and Soul Study. Am J Hypertens. 2006;19:939–946.
   Google Scholar
• Ratto E, Leoncini G, Viazzi F, Bezzante GP, Falqui V, Parodi A, . Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension. J Hypertens. 2008;26:345–350.
   Google Scholar
• Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertens Res. 2007;30:1177–1185.
   PubMed Web of Science ®Google Scholar
• Mehta SK, Rame JE, Khera A, Murphy SA, Canham RM, Peshock RM, . Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation. Hypertension. 2007;49:1385–1391.
   PubMed Web of Science ®Google Scholar